Drawing for ULIEHUFC

USPTO serial 50102245

ULIEHUFC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
VAN DEN ABEELEN, DEREK C
Law office
TMO LAW OFFICE 126

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with ULIEHUFC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian James Hamilton

185 Berry St Ste 400San Francisco, CA 94107United States

Goods and services

ClassDescriptionStatusFirst use
003Eye gels; Foot scrubs; Eyeliners; Make-up; Body oils; Body sprays; Teeth whitening kits comprised primarily of teeth whitening preparations; Bath bombs; Shower bombs; Skin creams; Exfoliant gels; Tanning gels; Hair conditionerACTIVEJul 30, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2026DOCKASSIGNED TO EXAMINER—
Sep 11, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance